Key Takeaways
- Deputy editors of Diabetes Care have published new details on ADA's ousting of five scientists.
- Accusations include prior knowledge and deliberate ambush by venue security.
- Criticism centers around the organization’s heavy-handed response to a public outcry.
The American Diabetes Association (ADA) has come under renewed scrutiny following the publication of new details in an editorial by its deputy editors. The incident, which occurred at the ADA's annual meeting last month, involved the ousting of five leading scientists who were handing out copies of a critical editorial published in the journal Diabetes Care.
The deputy editors have now posted their concerns on a preprint server, detailing what they claim are troubling actions taken by the ADA. According to the new documents, there is evidence that ADA leadership was aware in advance that members would distribute the controversial editorial and deliberately set up an ambush with venue security and local police.
This revelation adds another layer of complexity to the ongoing controversy. The deputy editors state that they were provided with the articles in advance and invited to publish a response alongside them, but their requests were ignored by the ADA leadership. This suggests a potential conflict between scientific integrity and organizational politics within the association.
The new details also highlight simmering tensions related to a session organized the year before, which may have contributed to the aggressive response from the ADA. The deputy editors argue that such actions undermine trust in the organization and its commitment to open dialogue and scientific freedom.
In an earlier statement, the ADA's CEO issued a personal apology for the heavy-handed response, acknowledging the distress caused by the incident. However, the new documents suggest that the underlying issues remain unresolved. The deputy editors assert that their articles should be published in full, emphasizing the importance of transparency and accountability within scientific communities.
The controversy has sparked widespread debate among medical professionals and researchers who are concerned about the impact on scientific discourse and the integrity of academic journals. Critics argue that such incidents can stifle open discussion and hinder progress in medical research.
We were provided with the articles in advance, but our requests to publish a response alongside them were ignored.
Deputy editors of Diabetes Care, Scientist
